SMBK:NYSESmartFinancial, Inc. Analysis
Data as of 2026-06-04 - not real-time
$40.65
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
SmartFinancial trades at $40.65, well below its DCF‑derived fair value of $62.74, implying roughly a 13% upside. The stock’s forward P/E of 9.68 is comfortably under the industry average of 16.4, and the current P/E of 13.0 reinforces a value‑oriented entry point. Operating margins of 38% and a profit margin of 27% highlight strong profitability, while an 8.3% revenue growth rate signals steady top‑line expansion. The dividend yield of 0.81% with a modest payout ratio of 10% and the recent announcement of a $0.09 dividend underscore the sustainability of cash returns. Technical signals are mixed: the price sits just above the $39.76 support level and below the $43.13 resistance, the 20‑day SMA (41.31) and 50‑day SMA (41.16) are marginally higher, and the MACD histogram is negative, suggesting short‑term downside pressure despite a bullish overall trend.
Risk is tempered by a beta of 0.88 and a 30‑day volatility of 23%, indicating moderate price swings. The balance sheet is strong, with $357.6 M in cash against $124.8 M of debt and a debt‑to‑equity of zero, reducing financial risk. The regional‑bank sector carries medium regulatory and geographic exposure, but the low currency risk and manageable liquidity profile (average volume ~57k) keep overall risk moderate. Given the undervalued valuation, solid fundamentals, and sustainable dividend, the stock presents an attractive opportunity for investors willing to ride short‑term technical noise for medium‑ to long‑term gains.
Risk is tempered by a beta of 0.88 and a 30‑day volatility of 23%, indicating moderate price swings. The balance sheet is strong, with $357.6 M in cash against $124.8 M of debt and a debt‑to‑equity of zero, reducing financial risk. The regional‑bank sector carries medium regulatory and geographic exposure, but the low currency risk and manageable liquidity profile (average volume ~57k) keep overall risk moderate. Given the undervalued valuation, solid fundamentals, and sustainable dividend, the stock presents an attractive opportunity for investors willing to ride short‑term technical noise for medium‑ to long‑term gains.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price hovering just above key support at $39.76
- Bearish MACD histogram indicating potential pullback
- Stable trading volume supporting price stability
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Undervalued relative to DCF fair value and industry P/E
- Strong operating margins and low leverage
- Sustainable dividend with low payout ratio
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Long‑term upside potential as price converges to fair value
- Consistent earnings growth and cash generation
- Resilient balance sheet enabling dividend continuity
Key Metrics & Analysis
Financial Health
Revenue Growth8.30%
Profit Margin26.85%
P/E Ratio13.0
ROE9.88%
ROA0.93%
P/B Ratio1.2
Op. Cash Flow$63.8M
Industry P/E16.4
Technical Analysis
TrendBullish
RSI45.0
Support$39.76
Resistance$43.13
MA 20$41.31
MA 50$41.16
MA 200$38.44
MACDBearish
VolumeStable
Fear & Greed Index91.73
Valuation
Fair Value$62.74
Target Price$46.15
Upside/Downside13.53%
GradeUndervalued
TypeBlend
Dividend Yield0.81%
Risk Assessment
Beta0.88
Volatility23.29%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.